type of intervention
Non-interventional, Observational
recruitment status
Recruiting
region
ACT, NSW, NT, QLD, SA, TAS, VIC, WA
type of ms
Clinically isolated syndrome, People without MS, Primary progressive MS, Relapsing MS, Relapsing remitting MS, Secondary progressive MS
You are invited to take part in a research study exploring quality of life and health economic impacts in patients accessing medicinal cannabis. People accessing medicinal cannabis may have a range of conditions and symptoms that impact their quality of life. We would like to know how these conditions and symptoms impact quality of life and if this changes over time while accessing medicinal cannabis. The results from this study will help future patients with these conditions to make better informed decisions about their treatment.
Visit www.thequestinitiative.com/how-it-works for a detailed overview about medication cost, participating doctors and how to enrol.
- 18+ years of age and over
- People with and without MS
- Diagnosed chronic condition who have tried other medications that have not been successful or have side effects.
- Eligible for medicinal cannabis as a form of treatment
•Have not taken any type of prescribed cannabis therapy for four weeks before enrolling in the study
•Pregnancy
•History of psychosis or schizophrenia
Ongoing
Please visit: www.thequestinitiative.com/ or email info@thequestinitiative.com
Details of the trial can be found at clinicaltrials.gov or on the ANZCTR clinical trials database.
Visit www.thequestinitiative.com/faq for frequently asked questions about this study.
NSW/ACT/SA/VIC/QLD/WA/TAS/NT
Yes
18/09/2025
